STING1 and neoplasm: Researchers have also reported agonists of STING that are not derived from CDNs but are amidobenzimidazole derivatives.163,164 Amidobenzimidazole derivatives are amenable to intravenous administration and therefore might be able to initiate immune responses towards multiple heterogenous, distal tumours.